Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Preclinical CRO Market by Type (Bioanalysis and DMPK Studies, Toxicology Testing, Others), By Application (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028-report

Global Preclinical CRO Market by Type (Bioanalysis and DMPK Studies, Toxicology Testing, Others), By Application (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Report ID: 136831 3300 Pharma & Healthcare Dataintelo 130 Pages
                                          

A detailed study on Preclinical CRO market complied by primary and secondary research and validated by industry experts. If you are planning to understand the Preclinical CRO market in and out, then this is a must have report. You will also get free analyst support with this report.

Preclinical CRO market is one of the markets, where investors have shown great interest. As per the research The global preclinical CRO market size was estimated at around USD 4.1 billion in 2019 and is anticipated to expand at a CAGR of around 8.3% over the forecast period. R&D budget for drug development has increased in recent years, leading to rising demand for preclinical CRO (Contract Research Organization) services, thus boosting the market growth during the forecast period. Preclinical CRO Market Sizes, Shares, Prices, Trends, and Forecasts have been derived from an in-depth study of the current scenarios in the. This report is based on both value and volume (Where applicable).

*This is a smart report which can be customized according to your need.

Highlights Of The Report:
1. Market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends.
3. Historical data and forecast.
4. Estimations for the forecast period between 2020 and 2026.
5. Developments and trends in the market.
6. By Type:
        Bioanalysis and DMPK Studies
        Toxicology Testing
        Others
7. By Application:
        Biopharmaceutical Companies
        Government and Academic Institutes
        Medical Device Companies
8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

Overview of the regional outlook of the market:

  • The report offers information about the regions in the market, which is further divided into sub-regions and countries.
  • In addition to the market share of each country and sub-region, information regarding lucrative opportunities is included in this chapter of the report.
  • Share and market growth rate of each region, country, and sub-region are mentions in this chapter of the report during the estimated time period.

Companies profiled in this report:
      1) Charles River Laboratories
      2) Laboratory Corporation of America
      3) Envigo
      4) Eurofins Scientific
      5) PRA Health Science
      6) Wuxi AppTec
      7) Medpace
      8) Pharmaceutical Product Development
      9) Paraxel
      10) COMPANY 10
*Additional companies can be added in Preclinical CRO market report as a part of free customization. Feel free to get in touch with our research analyst.

This chapter of the report comprises various key companies operating in the global market. This helps the reader understand the competitive landscape, including the strategies adopted by the players to stay in the competitive market.

  • Market Share
  • Company Profile
  • Business Information
  • SWOT Analysis
  • Strategies

Reasons To Purchase The Preclinical CRO Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
  • Moreover, we provide data support, in the excel format, and 1-year free analyst support.

                                            
1 Executive Summary

2 Assumptions and Acronyms Used

3 Research Methodology

4 Preclinical CRO Industry Overview
    4.1 Introduction
        4.1.1 Market Taxonomy
        4.1.2 Market Definition
    4.2 Macro-Economic Factors
        4.2.1 Industry Outlook
    4.3 Preclinical CRO Industry Dynamics
        4.3.1 Market Drivers
        4.3.2 Market Restraints
        4.3.3 Opportunity
        4.3.4 Market Trends
    4.4 Preclinical CRO Industry - Supply Chain
    4.5 Global Preclinical CRO Industry Forecast
        4.5.1 Preclinical CRO Industry Size (US$ Mn) and Y-o-Y Growth
        4.5.2 Preclinical CRO Industry Absolute $ Opportunity

5 Global Preclinical CRO Industry Analysis and Forecast by Services
    5.1 Market Trends
    5.2 Introduction
        5.2.1 Basis Point Share (BPS) Analysis by Services
        5.2.2 Y-o-Y Growth Projections by Services
    5.3 Preclinical CRO Industry Size Forecast by Services
        5.3.1 Bioanalysis and DMPK Studies
        5.3.2 Toxicology Testing (Kindly Refer Page No. 13 -14)
        5.3.3 Others
    5.4 Absolute $ Opportunity Assessment by Services
    5.5 Market Attractiveness/Growth Potential Analysis by Services

6 Global Preclinical CRO Industry Analysis and Forecast by End-user
    6.1 Market Trends
    6.2 Introduction
        6.2.1 Basis Point Share (BPS) Analysis by End-user
        6.2.2 Y-o-Y Growth Projections by End-user
    6.3 Preclinical CRO Industry Size Forecast by End-user
        6.3.1 Biopharmaceutical Companies
        6.3.2 Government and Academic Institutes
        6.3.3 Medical Device Companies
    6.4 Absolute $ Opportunity Assessment by End-user
    6.5 Market Attractiveness/Growth Potential Analysis by End-user

7 Global Preclinical CRO Industry Analysis and Forecast by Region
    7.1 Market Trends
    7.2 Introduction
        7.2.1 Basis Point Share (BPS) Analysis by Region
        7.2.2 Y-o-Y Growth Projections by Region
    7.3 Preclinical CRO Industry Size Forecast by Region
        7.3.1 North America
        7.3.2 Europe
        7.3.3 Asia Pacific
        7.3.4 Latin America
        7.3.5 Middle East and Africa (MEA)
    7.4 Absolute $ Opportunity Assessment by Region
    7.5 Market Attractiveness/Growth Potential Analysis by Region

8 Coronavirus Disease (COVID-19) Impact
    8.1 Introduction
    8.2 Market Trends
    8.3 Patient Data
    8.4 Current Impact Analysis
    8.5 Future Impact Analysis
    8.6 Economic Impact Analysis
    8.7 Government Policies
    8.8 Investment Scenario

9 North America Preclinical CRO Industry Analysis and Forecast
    9.1 Introduction
        9.1.1 Basis Point Share (BPS) Analysis by Country
        9.1.2 Y-o-Y Growth Projections by Country
    9.2 North America Preclinical CRO Industry Size Forecast by Country
        9.2.1 U.S.
        9.2.2 Canada
    9.3 Absolute $ Opportunity Assessment by Country
    9.4 North America Preclinical CRO Industry Size Forecast by Services
        9.4.1 Bioanalysis and DMPK Studies
        9.4.2 Toxicology Testing
        9.4.3 Others
    9.5 Basis Point Share (BPS) Analysis by Services
    9.6 Y-o-Y Growth Projections by Services
    9.7 North America Preclinical CRO Industry Size Forecast by End-user
        9.7.1 Biopharmaceutical Companies
        9.7.2 Government and Academic Institutes
        9.7.3 Medical Device Companies
    9.8 Basis Point Share (BPS) Analysis by End-user
    9.9 Y-o-Y Growth Projections by End-user
    9.10 Market Attractiveness/Growth Potential Analysis
        9.10.1 By Country
        9.10.2 By Services
        9.10.3 By End-user

10 Europe Preclinical CRO Industry Analysis and Forecast
    10.1 Introduction
        10.1.1 Basis Point Share (BPS) Analysis by Country
        10.1.2 Y-o-Y Growth Projections by Country
    10.2 Europe Preclinical CRO Industry Size Forecast by Country
        10.2.1 Germany
        10.2.2 France
        10.2.3 Italy
        10.2.4 U.K.
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Absolute $ Opportunity Assessment by Country
    10.4 Europe Preclinical CRO Industry Size Forecast by Services
        10.4.1 Bioanalysis and DMPK Studies
        10.4.2 Toxicology Testing
        10.4.3 Others
    10.5 Basis Point Share (BPS) Analysis by Services
    10.6 Y-o-Y Growth Projections by Services
    10.7 Europe Preclinical CRO Industry Size Forecast by End-user
        10.7.1 Biopharmaceutical Companies
        10.7.2 Government and Academic Institutes
        10.7.3 Medical Device Companies
    10.8 Basis Point Share (BPS) Analysis by End-user
    10.9 Y-o-Y Growth Projections by End-user
    10.10 Market Attractiveness/Growth Potential Analysis
        10.10.1 By Country
        10.10.2 By Services
        10.10.3 By End-user

11 Asia Pacific Preclinical CRO Industry Analysis and Forecast
    11.1 Introduction
        11.1.1 Basis Point Share (BPS) Analysis by Country
        11.1.2 Y-o-Y Growth Projections by Country
    11.2 Asia Pacific Preclinical CRO Industry Size Forecast by Country
        11.2.1 China
        11.2.2 Japan
        11.2.3 South Korea
        11.2.4 India
        11.2.5 Australia
        11.2.6 Rest of Asia Pacific (APAC)
    11.3 Absolute $ Opportunity Assessment by Country
    11.4 Asia Pacific Preclinical CRO Industry Size Forecast by Services
        11.4.1 Bioanalysis and DMPK Studies
        11.4.2 Toxicology Testing
        11.4.3 Others
    11.5 Basis Point Share (BPS) Analysis by Services
    11.6 Y-o-Y Growth Projections by Services
    11.7 Asia Pacific Preclinical CRO Industry Size Forecast by End-user
        11.7.1 Biopharmaceutical Companies
        11.7.2 Government and Academic Institutes
        11.7.3 Medical Device Companies
    11.8 Basis Point Share (BPS) Analysis by End-user
    11.9 Y-o-Y Growth Projections by End-user
    11.10 Market Attractiveness/Growth Potential Analysis
        11.10.1 By Country
        11.10.2 By Services
        11.10.3 By End-user

12 Latin America Preclinical CRO Industry Analysis and Forecast
    12.1 Introduction
        12.1.1 Basis Point Share (BPS) Analysis by Country
        12.1.2 Y-o-Y Growth Projections by Country
    12.2 Latin America Preclinical CRO Industry Size Forecast by Country
        12.2.1 Brazil
        12.2.2 Mexico
        12.2.3 Rest of Latin America
    12.3 Absolute $ Opportunity Assessment by Country
    12.4 Latin America Preclinical CRO Industry Size Forecast by Services
        12.4.1 Bioanalysis and DMPK Studies
        12.4.2 Toxicology Testing
        12.4.3 Others
    12.5 Basis Point Share (BPS) Analysis by Services
    12.6 Y-o-Y Growth Projections by Services
    12.7 Latin America Preclinical CRO Industry Size Forecast by End-user
        12.7.1 Biopharmaceutical Companies
        12.7.2 Government and Academic Institutes
        12.7.3 Medical Device Companies
    12.8 Basis Point Share (BPS) Analysis by End-user
    12.9 Y-o-Y Growth Projections by End-user
    12.10 Market Attractiveness/Growth Potential Analysis
        12.10.1 By Country
        12.10.2 By Services
        12.10.3 By End-user

13 Middle East & Africa Preclinical CRO Industry Analysis and Forecast
    13.1 Introduction
        13.1.1 Basis Point Share (BPS) Analysis by Country
        13.1.2 Y-o-Y Growth Projections by Country
    13.2 MEA Preclinical CRO Industry Size Forecast by Country
        13.2.1 Saudi Arabia
        13.2.2 South Africa
        13.2.3 UAE
        13.2.4 Rest of MEA
    13.3 Absolute $ Opportunity Assessment by Country
    13.4 MEA Preclinical CRO Industry Size Forecast by Services
        13.4.1 Bioanalysis and DMPK Studies
        13.4.2 Toxicology Testing
        13.4.3 Others
    13.5 Basis Point Share (BPS) Analysis by Services
    13.6 Y-o-Y Growth Projections by Services
    13.7 MEA Preclinical CRO Industry Size Forecast by End-user
        13.7.1 Biopharmaceutical Companies
        13.7.2 Government and Academic Institutes
        13.7.3 Medical Device Companies
    13.8 Basis Point Share (BPS) Analysis by End-user
    13.9 Y-o-Y Growth Projections by End-user
    13.10 Market Attractiveness/Growth Potential Analysis
        13.10.1 By Country
        13.10.2 By Services
        13.10.3 By End-user

14 Competition Landscape
    14.1 Global Preclinical CRO Industry: Market Share Analysis
    14.2 Preclinical CRO Distributors and Customers
    14.3 Preclinical CRO Industry: Competitive Dashboard
    14.4 Company Profiles (Details – Overview, Financials, Developments, Strategy)
        14.4.1 Envigo Corporation
        14.4.2 Eurofins Scientific
        14.4.3 ICON Plc.
        14.4.4 Laboratory Corporation of America, Inc.
        14.4.5 Medpace, Inc.
        14.4.6 MPI research
        14.4.7 PARAXEL International Corporation
        14.4.8 Pharmaceutical Product Development (PPD), LLC
        14.4.9 PRA Health Sciences, Inc
        14.4.10 Wuxi AppTec

Our Trusted Clients

Contact Us